BioNexus Gene Lab (BGLC) Dividend Coverage Ratio (2023 - 2024)
BioNexus Gene Lab's (BGLC) quarterly Dividend Coverage Ratio came in at 553.88 in Q3 2024, up 45.19% year-over-year from 381.49 in Q4 2023, and down 610.19% quarter-over-quarter from 108.56 in Q2 2024.
Powered by 
Analysis
BioNexus Gene Lab (BGLC) Dividend Coverage Ratio (2023 - 2024) Analysis & Trends
BioNexus Gene Lab has disclosed Dividend Coverage Ratio across 2 years of filings, most recently posting 553.88 for Q3 2024.
- In Q3 2024, Dividend Coverage Ratio rose 45.19% year-over-year to 553.88; the TTM figure through Sep 2024 stood at 99.21 (changed N/A YoY), while the FY2023 annual figure was 296.16, down 1632.84% from the prior year.
- Dividend Coverage Ratio came in at 553.88 for Q3 2024 at BioNexus Gene Lab, down from 108.56 in the prior quarter.
- In the past five years, Dividend Coverage Ratio ranged from a high of 168.75 in Q4 2023 to a low of 1010.53 in Q3 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | W.W. Grainger | 62.38 Bn | 62.17 Bn | 1.98 Bn | 4.14 |
| 2 | Fastenal | 56.92 Bn | 56.71 Bn | 1.06 Bn | 1.39 |
| 3 | Ferguson Enterprises | 44.34 Bn | 43.52 Bn | 2.32 Bn | 2.38 |
| 4 | Reliance | 20.45 Bn | 20.23 Bn | 1.30 Bn | 5.06 |
| 5 | Wesco International | 17.12 Bn | 16.31 Bn | 1.46 Bn | 8.57 |
| 6 | Applied Industrial Technologies | 11.98 Bn | 11.86 Bn | 411.22 Mn | 6.28 |
| 7 | Watsco | 11.22 Bn | 11.23 Bn | 578.93 Mn | 1.43 |
| 8 | Avantor | 10.13 Bn | 9.82 Bn | 537.00 Mn | - |
| 9 | Core & Main | 8.33 Bn | 8.25 Bn | 520.00 Mn | 56.50 |
| 10 | BioNexus Gene Lab | 2.60 Mn | -922,180.04 | 12,982.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | -553.88 |
| Jun 30, 2024 | 108.56 |
| Mar 31, 2024 | -38.27 |
| Dec 31, 2023 | 168.75 |
| Sep 30, 2023 | -1,010.53 |
| Jun 30, 2023 | -119.70 |
| Mar 31, 2023 | -38.82 |